Humacyte's total assets for Q1 2026 were $110.56M, a decrease of -4.99% from the previous quarter. HUMA total liabilities were $98.93M for the fiscal quarter, a -12.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.